Acacia subsidiary obtains patent for stent graft technology

Published on September 11, 2012 at 8:11 AM · No Comments

Acacia Research Corp (Nasdaq:ACTG) announced today that a subsidiary has acquired a patent for stent graft technology.    

"Acacia continues to increase the number of patent portfolios we control in the medical device and diagnostics sectors," commented Paul Ryan, CEO. "Acacia is expanding its presence as a leader in patent licensing for both the technology and medical technology sectors."



Posted in: Device / Technology News | Medical Patent News

Tags: ,

Read in | English | Español | Français | Deutsch | Português | Italiano | 日本語 | 한국어 | 简体中文 | 繁體中文 | Nederlands | Русский | Svenska | Polski
The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.
Post a new comment
You might also like... ×
Scientists use 3-D printing to develop customized biodegradable stents